# Considering Opportunities and Challenges When Implementing the Model Master File Framework – a Meeting Report

**Authors:** Eleftheria Tsakalozou, Lanyan Fang, Erin Skoda, Timothy Nicholas, Sivacharan Kollipara, Ke Ren, Stella Grosser, Bhagwant Rege, Partha Roy, Hao Zhu, Liang Zhao

PMC · DOI: 10.1007/s11095-025-03839-x · Pharmaceutical Research · 2025-03-07

## Abstract

The online version contains supplementary material available at 10.1007/s11095-025-03839-x.

## Full-text entities

- **Genes:** SLC6A3 (solute carrier family 6 member 3) [NCBI Gene 6531] {aka DAT, DAT1, PKDYS, PKDYS1}
- **Diseases:** MDLC (MESH:D002658), DMD (MESH:D020388), COVID-19 (MESH:D000086382), liver and kidney impaired (MESH:D017093), DMF (MESH:C000722848), renal impairment (MESH:D007674), Parkinson's disease (MESH:D010300)
- **Chemicals:** ANDA (-)
- **Species:** Homo sapiens (human, species) [taxon 9606], Hepacivirus P (species) [taxon 2202225]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12158848/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12158848/full.md

## References

11 references — full list in the complete paper: https://tomesphere.com/paper/PMC12158848/full.md

---
Source: https://tomesphere.com/paper/PMC12158848